Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00762736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study of the Efficacy, Safety, and Tolerability of Pioglitazone HCl (ACTOS™) in Combination With TAK-536 in Subjects With Type II Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy of pioglitazone, once daily (QD), combined with azilsartan in the treatment of subjects with Type 2 Diabetes Mellitus.
Study identification
- NCT ID
- NCT00762736
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 704 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Oct 2005 (Actual)
- Completion
- Oct 2005 (Actual)
- Last update posted
- Feb 28, 2012
2004 – 2005
United States locations
- U.S. sites
- 64
- U.S. states
- 24
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Sierra Vista | Arizona | — | — |
| Not listed | Sun City | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Burbank | California | — | — |
| Not listed | Escondido | California | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Spring Valley | California | — | — |
| Not listed | Coral Gables | Florida | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Opa-locka | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | Vero Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Warner Robins | Georgia | — | — |
| Not listed | Honolulu | Hawaii | — | — |
| Not listed | Lihue | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Dyersburg | Indiana | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Salisbury | Massachusetts | — | — |
| Not listed | Cadillac | Michigan | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Livonia | Michigan | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | North Las Vegas | Nevada | — | — |
| Not listed | Berlin | New Jersey | — | — |
| Not listed | Blackwood | New Jersey | — | — |
| Not listed | Trenton | New Jersey | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Kingston | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Marion | Ohio | — | — |
| Not listed | Clinton | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Scotland | Pennsylvania | — | — |
| Not listed | Woonsocket | Rhode Island | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Midland | Texas | — | — |
| Not listed | North Richard Hills | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Renton | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00762736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 28, 2012 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00762736 live on ClinicalTrials.gov.